ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MIST Milestone Pharmaceuticals Inc

1.63
-0.03 (-1.81%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Milestone Pharmaceuticals Inc MIST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -1.81% 1.63 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.66 1.50 1.6764 1.58 1.66
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/04/202409:00EDGAR2Form 8-K - Current report
3/01/202416:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202407:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
2/28/202416:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
2/26/202407:06EDGAR2Form 8-K - Current report
2/14/202420:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202407:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/26/202308:54DJNMilestone Pharmaceuticals Shares Sink 24% After Receiving..
12/26/202307:57DJNMilestone Pharmaceuticals' Etripamil Nasal Spray Application..
12/26/202307:15EDGAR2Form 8-K - Current report
11/21/202307:00PRNUSMilestone Pharmaceuticals to Present at the Piper Sandler..
11/13/202307:05EDGAR2Form 8-K - Current report
11/13/202306:57PRNUSMilestone Pharmaceuticals Reports Third Quarter 2023..
11/13/202306:37EDGAR2Form 8-K - Current report
11/13/202306:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202310:00PRNUSMilestone Pharmaceuticals Presents Positive Results from..
11/09/202316:43EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/07/202309:07EDGAR2Form 8-K - Current report
11/07/202307:00PRNCAMilestone Pharmaceuticals to Host Investor and Analyst..
10/24/202316:05EDGAR2Form 8-K - Current report
10/24/202307:00PRNCAMilestone Pharmaceuticals Announces Submission of New Drug..
10/06/202307:00PRNUSMilestone Pharmaceuticals Reports Inducement Grants Under..
9/27/202307:00PRNCAMilestone Pharmaceuticals Announces Etripamil AFib-RVR Study..
9/05/202307:00PRNCAMilestone Pharmaceuticals to Present at the H.C. Wainwright..
8/10/202307:40EDGAR2Form 8-K - Current report
8/10/202307:35PRNUSMilestone Pharmaceuticals Reports Second Quarter 2023..
8/10/202307:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/20/202307:00PRNCAMilestone Pharmaceuticals Announces Publication of Results..
6/01/202307:00PRNCAMilestone Pharmaceuticals to Present at the Jefferies..
5/22/202307:00PRNUSMilestone Pharmaceuticals Announces Presentation of Data..
5/11/202307:16PRNCAMilestone Pharmaceuticals Reports First Quarter 2023..
5/08/202307:00PRNUSMilestone Pharmaceuticals to Host Virtual Key Opinion Leader..

Your Recent History

Delayed Upgrade Clock